In the News

Tabula Rasa HealthCare Announces Preliminary Fourth Quarter and Full Year 2020 Unaudited Revenue and Select PACE Operating Metrics

MOORESTOWN, N.J., January 12, 2021 — Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing safer use of medications, today announced preliminary, unaudited financial results and select PACE operating metrics for the fourth quarter and the full year ended December 31, 2020. Full year 2020 revenue is expected to be at the top end of our guidance range of $294 million to $296 million. TRHC expects to announce profitability and, specifically, non-GAAP adjusted EBITDA, on February 23,... Read More

TRHC Featured in Next Avenue’s Why COVID-19 Could Pose New Medication Risks

Why COVID-19 Could Pose New Medication Risks Next Avenue By Michele Cohen Marill December 1, 2020   It’s common for older adults to take multiple medications, whether they’re for easing pain, lowering blood pressure or cholesterol or treating a chronic condition. Yet the COVID-19 pandemic has amplified concerns about polypharmacy – regularly taking five or more prescription drugs. Some prescriptions have side effects, such as dizziness, that can be particularly dangerous for older people; others... Read More

TRHC Featured in mHealthIntelligence for Collaboration on CDC National Diabetes Prevention Program

The APhA Foundation announced last month that it would join forces with The Kroger Company and Tabula Rasa HealthCare to add connected health elements to its CDC-approved National Diabetes Prevention Program, called Project IMPACT: Diabetes Prevention. The program, unveiled in 2017, aims to push health and wellness resources and coaching to at-risk populations across the country through pharmacies serving those populations.   Read more in mHealthIntelligence.

TRHC Chief Scientific Officer Featured in Today’s Geriatric Medicine

Jacques Turgeon, BPharm, PhD, chief scientific officer of Tabula Rasa HealthCare (TRHC) and Veronique Michaud, BPharm, MSc, PhD, chief operation officer of TRHC Precision Pharmacotherapy Research & Development Institute, authored “Medication Monitor: Decreasing Adverse Drug Events” in the January/February issue of Today’s Geriatric Medicine Magazine. Read the full article.